Andrea Matthews
Corporate Officer/Principal bij ASTRIA THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Andrea L.
Matthews is currently the Chief Business Officer at Astria Therapeutics, Inc. She started this position in 2023.
Prior to her current role, she worked at Selventa, Inc. as the Vice President-Commercial Operations from 2010 to 2014.
Ms. Matthews completed her undergraduate degree at Boston University and holds an MBA from MIT Sloan School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-02-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Andrea Matthews
| Bedrijven | Functie | Begin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Corporate Officer/Principal | 19-04-2023 |
Eerdere bekende functies van Andrea Matthews
| Bedrijven | Functie | Einde |
|---|---|---|
Selventa, Inc.
 Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 16-03-2010 |
Opleiding van Andrea Matthews
| Boston University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Selventa, Inc.
Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
